Cargando…
Pathogenic Role of Immune Evasion and Integration of Human Papillomavirus in Oropharyngeal Cancer
The incidence of oropharyngeal cancer (OPC) is increasing remarkably among all head and neck cancers, mainly due to its association with the human papillomavirus (HPV). Most HPVs are eliminated by the host’s immune system; however, because HPV has developed an effective immune evasion mechanism to c...
Autores principales: | Hatano, Takashi, Sano, Daisuke, Takahashi, Hideaki, Oridate, Nobuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143538/ https://www.ncbi.nlm.nih.gov/pubmed/33919460 http://dx.doi.org/10.3390/microorganisms9050891 |
Ejemplares similares
-
Pretreatment prognostic factor for patients with human papillomavirus related oropharyngeal cancer
por: Sano, Daisuke, et al.
Publicado: (2019) -
A prospective clinical trial of the second‐look procedure for transoral surgery in patients with T1 and T2 laryngeal, oropharyngeal, and hypopharyngeal cancer
por: Nishimura, Goshi, et al.
Publicado: (2019) -
Long-term efficacy of immune checkpoint inhibitors with or without chemotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck: a commentary on the 4-year follow-up of the KEYNOTE-048 trial
por: Sano, Daisuke, et al.
Publicado: (2023) -
JunB promotes cell invasion, migration and distant metastasis of head and neck squamous cell carcinoma
por: Hyakusoku, Hiroshi, et al.
Publicado: (2016) -
The Second-Look Procedure for Transoral Videolaryngoscopic Surgery for T1 and T2 Laryngeal, Oropharyngeal, and Hypopharyngeal Cancer Patients: Protocol for a Nonrandomized Clinical Trial
por: Nishimura, Goshi, et al.
Publicado: (2017)